<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H338C456342AC4A988415B8997D4168B0" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 5163 IH: TREATS Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-08-04</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5163</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230804">August 4, 2023</action-date><action-desc><sponsor name-id="T000483">Mr. Trone</sponsor> (for himself and <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.</official-title></form><legis-body id="H335F4E3F1C0D4ED3A93CF5AEFB27AED2" style="OLC"><section id="H8C2499041C00436BA272EF9BCAC55AF8" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Telehealth Response for E-prescribing Addiction Therapy Services Act</short-title></quote> or <quote>TREATS Act</quote>.</text></section><section id="HFC2929B025D4457B82B96DD5AA4FE5DA"><enum>2.</enum><header>Telehealth for substance use disorder treatment</header><text display-inline="no-display-inline">Section 309(e)(2) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/829">21 U.S.C. 829(e)(2)</external-xref>) is amended—</text><paragraph id="H5AFECA0022634114A991D680F7AB3A23"><enum>(1)</enum><text>in subparagraph (A)(i)—</text><subparagraph id="H4DC0FFDF85B246CAB6C2121718D025A6"><enum>(A)</enum><text>by striking <quote>at least 1 in-person medical evaluation</quote> and inserting the following: </text><quoted-block style="OLC" id="H0CF390D17AC742ACBFD521329638B088" display-inline="yes-display-inline"><text>at least—</text><subclause id="H36A0762E95704A67B6B3CE0F98B8DA81"><enum>(I)</enum><text display-inline="yes-display-inline">1 in-person medical evaluation</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph id="HE57D7790A29A41E584BBC66D93C6953A"><enum>(B)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H86DF7FAD656A4D0583C5B67549E5BA02" display-inline="no-display-inline"><subclause id="HAAAE3E5959D84882868FBEB22135EA0B"><enum>(II)</enum><text display-inline="yes-display-inline">for purposes of prescribing a controlled substance in schedule III, IV, or V that is approved by the Food and Drug Administration for the treatment of opioid use disorder (other than methadone), 1 telehealth evaluation; or</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H311C53D146234A369BD0E0566098CF31"><enum>(2)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="HB5EDDCD7513A438DA6483F9D7C1580F2" display-inline="no-display-inline"><subparagraph id="H100BF680C56746ED8A08DDE045B10D94"><enum>(D)</enum><text display-inline="yes-display-inline">The term ‘telehealth evaluation’ means a medical evaluation that is conducted in accordance with applicable Federal and State laws by a practitioner (other than a pharmacist) who is at a location remote from the patient and is communicating with the patient, or a health care professional who is treating the patient, using a telecommunications system referred to in section 1834(m) of the Social Security Act that includes audio-only or audio and video equipment permitting two-way, real-time interactive communication between the patient and distant site practitioner or health care professional who is treating the patient.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill> 

